NO955071L - abeo-Ergolin-derivater som 5HT1A-ligander - Google Patents

abeo-Ergolin-derivater som 5HT1A-ligander

Info

Publication number
NO955071L
NO955071L NO955071A NO955071A NO955071L NO 955071 L NO955071 L NO 955071L NO 955071 A NO955071 A NO 955071A NO 955071 A NO955071 A NO 955071A NO 955071 L NO955071 L NO 955071L
Authority
NO
Norway
Prior art keywords
group
alkyl
phenyl
formula
hydrogen atom
Prior art date
Application number
NO955071A
Other languages
English (en)
Norwegian (no)
Other versions
NO955071D0 (no
Inventor
Sergio Mantegani
Tiziano Bandiera
Enzo Brambilla
Carla Caccia
Nicola Carfagna
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of NO955071D0 publication Critical patent/NO955071D0/no
Publication of NO955071L publication Critical patent/NO955071L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO955071A 1994-04-18 1995-12-14 abeo-Ergolin-derivater som 5HT1A-ligander NO955071L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407637A GB9407637D0 (en) 1994-04-18 1994-04-18 Serotoninergic abeo-ergoline derivatives
PCT/EP1995/001398 WO1995028403A1 (en) 1994-04-18 1995-04-13 Abeo-ergoline derivatives as 5ht1a ligands

Publications (2)

Publication Number Publication Date
NO955071D0 NO955071D0 (no) 1995-12-14
NO955071L true NO955071L (no) 1995-12-14

Family

ID=10753700

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955071A NO955071L (no) 1994-04-18 1995-12-14 abeo-Ergolin-derivater som 5HT1A-ligander

Country Status (16)

Country Link
US (1) US6284896B1 (de)
EP (1) EP0708777B1 (de)
JP (1) JPH08512059A (de)
KR (1) KR960703126A (de)
CN (1) CN1126996A (de)
AT (1) ATE255111T1 (de)
CA (1) CA2163773A1 (de)
DE (1) DE69532187T2 (de)
ES (1) ES2211903T3 (de)
FI (1) FI955933A0 (de)
GB (1) GB9407637D0 (de)
HU (1) HUT73430A (de)
NO (1) NO955071L (de)
NZ (1) NZ284472A (de)
PL (1) PL312229A1 (de)
WO (1) WO1995028403A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2825100A (en) * 1999-03-30 2000-10-23 Shionogi & Co., Ltd. Heterocyclic compounds having affinities for serotonin receptors
MXPA03001472A (es) * 2000-08-16 2003-06-06 Upjohn Co Compuestos para el tratamiento de trastornos adictivos.
JPWO2002024641A1 (ja) * 2000-09-22 2004-01-29 塩野義製薬株式会社 セロトニン受容体親和性を有する三環性インドール化合物
IL325904A (en) * 2023-07-14 2026-03-01 2A Biosciences Inc Modified ergolines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1482871A (en) * 1975-03-18 1977-08-17 Farmaceutici Italia Tetracyclic indole derivatives
IL59507A (en) 1979-03-16 1984-01-31 Erba Farmitalia 5-(10-9)abeo-6-methylergoline derivatives,their preparation and pharmaceutical compositions containing them
GB8714767D0 (en) 1987-06-24 1987-07-29 Erba Farmitalia Egoline derivatives
GB8612366D0 (en) 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8702364D0 (en) 1987-02-03 1987-03-11 Erba Farmitalia Ergolinyl heterocycles
DE3868866D1 (de) 1987-11-20 1992-04-09 Erba Carlo Spa Ergolinderivate mit antiparkinsonwirkung.
US5210194A (en) 1990-01-25 1993-05-11 Farmitalia Carlo Erba S.R.L. An Italian Body Corporate Process for preparing ergoline derivatives
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
EP0628042B1 (de) 1992-12-24 2001-08-16 PHARMACIA & UPJOHN S.p.A. Serotoninergische ergolin derivate

Also Published As

Publication number Publication date
PL312229A1 (en) 1996-04-01
CN1126996A (zh) 1996-07-17
CA2163773A1 (en) 1995-10-26
NO955071D0 (no) 1995-12-14
AU2307395A (en) 1995-11-10
DE69532187D1 (de) 2004-01-08
ATE255111T1 (de) 2003-12-15
FI955933L (fi) 1995-12-11
JPH08512059A (ja) 1996-12-17
AU685268B2 (en) 1998-01-15
DE69532187T2 (de) 2004-09-02
WO1995028403A1 (en) 1995-10-26
EP0708777B1 (de) 2003-11-26
HU9503718D0 (en) 1996-03-28
GB9407637D0 (en) 1994-06-08
US6284896B1 (en) 2001-09-04
FI955933A7 (fi) 1995-12-11
HUT73430A (en) 1996-07-29
ES2211903T3 (es) 2004-07-16
FI955933A0 (fi) 1995-12-11
KR960703126A (ko) 1996-06-19
EP0708777A1 (de) 1996-05-01
NZ284472A (en) 1998-01-26

Similar Documents

Publication Publication Date Title
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
DK0870765T3 (da) Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
DE69418704D1 (de) Anthranilsäure derivate
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
IE42410L (en) Olefinic derivatives of aminoacids.
YU16899A (sh) Aralkil i aralkiliden heterociklicni laktami i imidi
MY149463A (en) Novel compounds
DK34793A (da) Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det
NO20080738L (no) Fremgangsmater for neurobeskyttelse
DK0594263T3 (da) Mellemprodukter til fremstilling af thioalkylthio-cephalosporinderivater
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
CS34491A3 (en) Substituted benzimidazole and idazole derivatives, process of their preparation and the use of these derivatives
NO20020621L (no) Antibakterielle midler
DK0458551T3 (da) Spiro-isoquinolin-pyrrolidiner og analoge deraf, som er anvendelige som aldosereduktase-inhibitorer.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
FI844333A0 (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NZ241157A (en) Heterocyclically-substituted benzofuran derivatives, preparation and pharmaceutical compositions thereof
NO955071L (no) abeo-Ergolin-derivater som 5HT1A-ligander
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
AU6731100A (en) Integrase inhibitors containing aromatic heterocycle derivatives
DK508484D0 (da) N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem
GR3001765T3 (en) Imidazolidinedione derivatives
DE69005318D1 (de) 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen.
IT1150955B (it) Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono